BETHESDA, Md., Oct. 14 -- The U.S. Department of Health & Human Services' National Institutes of Health issued the following press release:
In a National Institutes of Health (NIH)-funded study, scientists have demonstrated that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism. Researchers initially discovered the connection between brown fat and the drug class to which losartan belongs, known as angiotensin receptor blockers (ARBs), through an analysis of over 100,000 patients. This indicates that repurposing a widely used drug, with a well-known safety profile, may be a clinically viable method of stimulating brown fat, which has been linked to improv...